Dr. Mrignayani Kotecha is a founding member, President and CEO of Chicago-based biotech company O2M Technologies. In this role, Dr. Kotecha provides guidance and leadership to develop EPROI (eMRI)-based oxygen imagers for preclinical biomedical research and clinical applications in oncology. She also leads the “Oxygen Measurement Core” research facility that collaborates with leading academic, government, and industry members to perform cutting-edge research involving oxygen imaging. Dr. Kotecha has a PhD in Physics and 25+ years of experience in magnetic resonance technologies. She is currently co-editing a special issue for the journal “Molecular Imaging and Biology” about “EPR Imaging and Applications to Biology”.